Elevance Health raises 2026 guidance for Elevance Health stock

Published on 10/27/2026 at 11:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Elevance Health raised adjusted 2026 earnings guidance to at least USD 29.00. Elevance Health stock costs EUR 388.40 on October 27, 2026.

Guidance and earnings context

Adjusted 2026 earnings guidance reached at least USD 29.00 on October 21, 2026.
Third-quarter operating revenue reached USD 50.4 billion in 2026.
Elevance Health stock was trading at EUR 388.40 at 11:41 a.m. CET at Lang & Schwarz on October 27, 2026.
The fourth-quarter dividend has December 4, 2026 and December 18, 2026 as key dates.

Elevance Health, US0367521038, Illustration mit AI erstellt.

Elevance Health (ISIN US0367521038) was trading at EUR 388.40 at Lang & Schwarz on October 27, 2026 at 11:41 a.m. CET. The insurer raised its adjusted 2026 earnings guidance to at least USD 29.00 after reporting third-quarter results on October 21, 2026, according to Elevance Health.

Results improve as costs ease

Operating revenue reached USD 50.4 billion in the third quarter of 2026, up USD 0.4 billion from the year-earlier quarter. Adjusted diluted earnings per share came to USD 6.99, while GAAP diluted earnings per share reached USD 6.27, the company said in its October 21, 2026 release.

The benefit expense ratio improved to 90.6 percent from 91.3 percent in the third quarter of 2025. Operating cash flow reached USD 1.3 billion in the third quarter of 2026, and full-year operating cash flow guidance rose to at least USD 6.5 billion.

Three dated developments

On October 12, 2026, Guggenheim raised its Elevance Health price target to USD 460, according to MarketBeat. On October 20, 2026, Elevance Health declared a fourth-quarter dividend of USD 1.72 per share. On October 21, 2026, it reported third-quarter revenue of USD 50.4 billion and raised adjusted earnings guidance to at least USD 29.00, according to Elevance Health.

What dates matter next?

Shareholders of record on December 4, 2026 are scheduled to receive the USD 1.72 dividend on December 18, 2026, according to Elevance Health. The dates give the improved earnings outlook a separate cash-return component.

Stock trades during the session

Elevance Health operates through health benefits, pharmacy and healthcare service businesses. Its medical membership reached 44.9 million as of September 30, 2026, down 487,000 from the prior year, making membership trends an important counterweight to the improved benefit expense ratio.

Elevance Health was trading at EUR 388.40 at Lang & Schwarz on October 27, 2026 at 11:41 a.m. CET.

The further course of trading is shown by the continuously updated real-time quote of Elevance Health stock.